• Product NameExherin (trifluoroacetate)
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityExherin (ADH-1) trifluoroacetate is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities; selectively and competitively binds to and blocks N-cadherin.
• Target NameDehydrogenase inhibitor
• CAS No. 1135237-88-5
• Calculated MW 684.71
• Formulation C24H35F3N3O3S2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:C[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CN=CN2)NC(=O)C)C(=O)N)C(C)C.C(=O)(C(F)(F)F)O
  Pathways:Metabolism
  Receptor:N-cadherin
  Boling pt:
  Melting pt:
  Solubility:DMSO: 43 mg/Ml
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1.Perotti A, et al. Ann Oncol. 2009 Apr;20(4):741-5.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting